Standing Committee for the Centers for Disease Control and Prevention Division of Strategic National Stockpile
The National Academies of Sciences, Engineering, and Medicine has established a standing committee of experts to help inform decision-making by the CDC Division of Strategic National Stockpile (DSNS). The standing committee includes experts in state and local public health, medical countermeasure production, warehouse and product distribution, logistics management, emergency medical services, emergency medicine, risk communications, and Food and Drug Administration regulatory issues. The standing committee provides a venue for the exchange of ideas among federal, state, and local governmental agencies, the private sector, the academic community, and other relevant stakeholders.
Completed
Description
The Institute of Medicine will establish a standing committee of experts to help inform decision making by the Centers for Disease Control and Prevention's (CDC) Division of Strategic National Stockpile (SNS). The standing committee will include experts in state and local public health, medical countermeasure production, warehouse and product distribution, logistics management, emergency medical services, emergency medicine, risk communications, and Food and Drug Administration (FDA) regulatory issues. The standing committee will provide a venue for the exchange of ideas among federal, state, and local government agencies, the private sector, and the academic community, as well as other relevant stakeholders involved in emergency preparedness and emergency response services. Further, as needed, the standing committee will be involved in the planning, development, and oversight of related ad hoc activities undertaken by separately appointed committees operating under its auspices. In accordance with National Research Council policies, the standing committee itself will not produce or be used in the development of any reports.
The standing committee should:
- Stand ready to respond on short notice to requests and other needs from CDC,
- Provide a venue to enable discussions relevant to CDC on emerging issues, research, and activities through in-depth knowledge of the sponsor's programs, goals, and activities,
- Serve as a focal point for national policy discussions by experts and other leaders in the field, and
- Respond to CDC’s needs for continuing dialog related to their planning, strategic thinking, and program development.
Collaborators
Committee
Tara O'Toole
Chair
Raphael M. Barishansky
Member
Margaret L. Brandeau
Member
Perry L. Fri
Member
Larry Glasscock
Member
Diane E. Griffin
Member
Lewis Grossman
Member
Katherine L. Heilpern
Member
Sheldon H. Jacobson
Member
Eva K. Lee
Member
Boris D. Lushniak
Member
Erin Mullen
Member
Paul E. Petersen
Member
Lewis J. Radonovich
Member
Irwin Redlener
Member
Karen Remley
Member
Sara Roszak
Member
Linda Rouse-O'Neill
Member
Lewis Rubinson
Member
Richard Serino
Member
Umair A. Shah
Member
Steven A. Shapiro
Member
Skip I. Skivington
Member
Tener G. Veenema
Member
Scott Wollek
Staff Officer
Sponsors
Centers for Disease Control and Prevention
Department of Health and Human Services
Staff
Scott Wollek
Lead
Benjamin Kahn
Rebecca Ray
Major units and sub-units
Health and Medicine Division
Lead
Board on Health Sciences Policy
Lead